SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford

— Agreement to support development of a vaccine against EBV — Oxford, UK and Cambridge, MA (May 23, 2024) — SpyBiotech, a biotechnology company with novel vaccine platform technologies that can target infectious diseases, cancer, and chronic diseases, today announced a sponsored research agreement with The University of Oxford for the development of a vaccine […] The post SpyBiotech Adds Epstein-Barr Virus Research and Development Collaboration with The University of Oxford first appeared on SpyBiotech .